RA CAPITAL MANAGEMENT, L.P. bought EVMN

November 7, 2025 · Form 4 insider transaction

RA CAPITAL MANAGEMENT, L.P. bought 1,157,096 shares of Evommune, Inc. at $16.00 per share, a transaction worth $18.51M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction
Acquired (buy-side)
Shares
1,157,096
Price
$16.00
Total value
$18.51M
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 7, 2025
Filing dateNovember 12, 2025
Shares owned after2,674,425
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.; Held directly by the Fund.

View the original Form 4 on SEC EDGAR